JP2017537702A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537702A5
JP2017537702A5 JP2017529751A JP2017529751A JP2017537702A5 JP 2017537702 A5 JP2017537702 A5 JP 2017537702A5 JP 2017529751 A JP2017529751 A JP 2017529751A JP 2017529751 A JP2017529751 A JP 2017529751A JP 2017537702 A5 JP2017537702 A5 JP 2017537702A5
Authority
JP
Japan
Prior art keywords
population
umbilical cord
cells
human umbilical
cord tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017529751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/063923 external-priority patent/WO2016090215A2/en
Publication of JP2017537702A publication Critical patent/JP2017537702A/ja
Publication of JP2017537702A5 publication Critical patent/JP2017537702A5/ja
Pending legal-status Critical Current

Links

JP2017529751A 2014-12-05 2015-12-04 前駆細胞を用いた眼球症状の治療法 Pending JP2017537702A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462088429P 2014-12-05 2014-12-05
US62/088,429 2014-12-05
US201562126370P 2015-02-27 2015-02-27
US62/126,370 2015-02-27
US201562220873P 2015-09-18 2015-09-18
US62/220,873 2015-09-18
PCT/US2015/063923 WO2016090215A2 (en) 2014-12-05 2015-12-04 Treatment of ocular conditions using progenitor cells

Publications (2)

Publication Number Publication Date
JP2017537702A JP2017537702A (ja) 2017-12-21
JP2017537702A5 true JP2017537702A5 (cg-RX-API-DMAC10.html) 2019-03-22

Family

ID=56092673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017529751A Pending JP2017537702A (ja) 2014-12-05 2015-12-04 前駆細胞を用いた眼球症状の治療法

Country Status (16)

Country Link
US (1) US20160158293A1 (cg-RX-API-DMAC10.html)
EP (1) EP3258946A4 (cg-RX-API-DMAC10.html)
JP (1) JP2017537702A (cg-RX-API-DMAC10.html)
KR (1) KR20170093178A (cg-RX-API-DMAC10.html)
CN (1) CN107206028A (cg-RX-API-DMAC10.html)
AU (1) AU2015358330A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017011513A2 (cg-RX-API-DMAC10.html)
CA (1) CA2969690A1 (cg-RX-API-DMAC10.html)
HK (1) HK1250329A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007207A (cg-RX-API-DMAC10.html)
PH (1) PH12017500998A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017123184A (cg-RX-API-DMAC10.html)
SG (1) SG11201704268TA (cg-RX-API-DMAC10.html)
TW (1) TW201636032A (cg-RX-API-DMAC10.html)
WO (1) WO2016090215A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704521B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
JP7348892B2 (ja) * 2019-12-30 2023-09-21 佛教慈濟醫療財團法人 眼疾患を予防または治療する組成物及び方法
WO2021207282A2 (en) * 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
CA2761610C (en) * 2009-05-13 2020-12-29 Medipost Co., Ltd. Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
CN103998048A (zh) * 2011-07-11 2014-08-20 车比奥及戴奥斯泰有限公司 脐带提取物的制备方法和使用方法
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Similar Documents

Publication Publication Date Title
Chichagova et al. Cellular regeneration strategies for macular degeneration: past, present and future
Laschke et al. Three-dimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds
Dissanayaka et al. In vitro analysis of scaffold-free prevascularized microtissue spheroids containing human dental pulp cells and endothelial cells
Leong et al. Cardiac stem cells for myocardial regeneration: they are not alone
CA2747794C (en) Treatment of lung and pulmonary diseases and disorders
JP2014000094A5 (ja) 臍帯由来細胞を用いた局部的または散在的脳外傷の改善
JP2015159895A5 (cg-RX-API-DMAC10.html)
JP2017512842A5 (cg-RX-API-DMAC10.html)
Wan et al. Importance of the stem cell microenvironment for ophthalmological cell-based therapy
RU2017124983A (ru) Лечение дегенерации сетчатки с использованием клеток-предшественников
JP2015096556A5 (cg-RX-API-DMAC10.html)
JP2015131795A5 (cg-RX-API-DMAC10.html)
JP2014516034A5 (cg-RX-API-DMAC10.html)
JP2016515382A5 (cg-RX-API-DMAC10.html)
JP2018522593A5 (cg-RX-API-DMAC10.html)
BRPI0922184A2 (pt) célula isolada, população isolada de células, matriz ou estrutura sintética permanente ou decelularizada degradável, e , método para tratar um indivíduo
JP2015524844A5 (cg-RX-API-DMAC10.html)
MX2023003296A (es) Generacion de lineas de cardiomiocitos auriculares y ventriculares a partir de celulas madre pluripotentes humanas.
RU2017123184A (ru) Лечение глазных патологий с применением клеток-предшественников
Vacca et al. MSC and innate immune cell interactions: a lesson from human decidua
JP2016027797A5 (cg-RX-API-DMAC10.html)
Nafissi et al. Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery
Santa Cruz-Pavlovich et al. Beyond vision: an overview of regenerative medicine and its current applications in ophthalmological care
Ji et al. Decellularized matrix of adipose-derived mesenchymal stromal cells enhanced retinal progenitor cell proliferation via the Akt/Erk pathway and neuronal differentiation
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?